HEADLINES                                                   Indian Market                                               I...
 MARKET ANALYSIS:         Key benchmark indices scaled fresh 7-month highs as pivotals extended gains in late trade. A s...
.            -GAINERS AND LOOSERS                                                                               EXPERT OP...
MARKET CALLS                                                                           CASH                               ...
Upcoming SlideShare
Loading in...5
×

DAILY EQUTY REPORT BY EPIC RESEARCH-17 SEPTEMBER 2012

107

Published on

Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack and NCDEX Tips. We provide services in equity, commodity and Forex market.

Published in: Economy & Finance, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
107
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "DAILY EQUTY REPORT BY EPIC RESEARCH-17 SEPTEMBER 2012"

  1. 1. HEADLINES  Indian Market Indian equity markets up by 2.62% . Nifty up by 142.30 pts and settle at 5577.65 Sensex up by 443.11 pts at 18464.27 Bank Nifty up by 435.10 pts at 10642.90 DAILY EQUITY  Global Market NEWSLETTER European markets were up with FTSE TH up by 96.47 pts at 5916.39 ,CAC up by 17 SEPTEMBER 2012 73.71 pts at 3575.80 and DAX up by 108.97 pts at 7419.29 Dow future up by 60.00 pts at 13580.00  HEADLINES• Bharti Infratel files DRHP, Bharti Airtel to stay away .• SBI sees no case for further CRR cut Now.• August inflation shoots up to 7.5% versus 6.87% in July.• Big bang reforms: Government to consider FDI in multi-brand retail, aviation. WWW.EPICRESEARCH.CO 09993959693
  2. 2.  MARKET ANALYSIS:  Key benchmark indices scaled fresh 7-month highs as pivotals extended gains in late trade. A steep hike of Rs 5 per liter on heavily subsidised diesel by the Cabinet Committee on Political Affairs (CCPA) on Thursday to bring down the burgeoning fiscal deficit and sustained buying by foreign funds bolstered sentiment.  The BSE Sensex was up 420 points or 2.33% to 18,441.16. The index surged 477.38 points at the days high of 18,498.54 in late trade.  The S&P CNX Nifty was up 132.05 points or 2.43% to 5,567.40. The index hit an intraday high of 5,586.65, its highest level since 22 February 2012.  Among the 30-share Sensex pack, 24 gained and only six of them declined.  Markets across the globe surged after the US central bank on Thursday initiated another aggressive stimulus program to stimulate growth in the worlds largest economy. Index heavyweight Reliance Industries (RIL) gained 5.05% to Rs 838.60. ICICI Bank surged 4.76% after the private sector bank cut deposit rates by 50 basis points and the revised rates were effective 11 September 2012. STOCKS TO WATCH  FII’s and DII’s  JUBILANT FOODSCATEGORY DATE BUY SELL NET  AURO PHARMA FII 14-Sep-12 5355.25 2521.53 2833.72  AMBUJA  ARVIND DII 14-Sep-12 1818.41 2506.41 -688 SCRIPS IN BAN PERIOD  NIFTY DAILY PIVOTS  COREEDUTECPIVOT R4 R3 R2 R1 PP S1 S2 S3 S4  HDILNIFTY 5743 5683 5623 5600 5563 5540 5503 5443 5383  MCDOWELL-N  SUZLON  WELCORP  JET AIRWAYS WWW.EPICRESEARCH.CO 09993959693
  3. 3. .  -GAINERS AND LOOSERS EXPERT OPINION NIFTY DAILY NIFTY GAINERS  Nifty looks BullishSCRIPS RATE VOL. PR. NET %  Strategy: Buy on dips (000) CLOSE CHAN CHANGE GE  Support:5540 Jindal 373.20 8390.12 341.90 31.30 9.15  Resistance: 5612 Steel BANK NIFTY 118.35 18890.28 109.55 8.80 8.03Hindalco  Bank Nifty looks Bullish DLF 216.60 7827.03 202.00 14.60 7.23  Strategy: Buy on dips JP Assoc 73.70 22440.47 69.15 4.55 6.58  Support:10580 Axis  Resistance:10710 1009.90 4716.53 948.05 61.85 6.52 Bank  PREVIOUS PERFORMANCE TYPE SCRIP B/S RESULT DAILY NIFTY LOOSERSSCRIPS RATE VOL. PR. NET % TGT CASH ARVIND B ACHIEVED (000) CLOSE CHAN NOT GE CASH CAIRN INDIA B EXECUTED TGT Ranbaxy 540.95 1229.44 551.25 -10.30 -1.87 FUTURE AMBUJA B ACHIEVED Dr Reddys 1747.50 467.25 1778.80 -31.30 -1.76 BHARTI NOT FUTURE AIRTEL S EXECUTED NTPC 168.30 3296.33 171.15 -2.85 -1.67 BPCL 350.20 4282.18 354.70 -4.50 -1.27 Power 120.00 7604.64 121.15 -1.15 -0.95 Grid www.epicresearch.co 09993959693
  4. 4. MARKET CALLS CASH ST ND RD SCRIPS ACTION LEVEL 1 TARGET 2 TARGET 3 TARGET STOP LOSS BHARTI AIRTEL BUY 257.30 259.30 261.80 264.80 254.30 DR REDDY SELL 1739.00 1729.00 1715.00 1699.00 1749.00 FUTURE ST ND RD SCRIPS ACTION LEVEL 1 TARGET 2 TARGET 3 TARGET STOP LOSS. AURO PHARMA SELL 124.40 123.85 121.85 120.50 124.95 JUBILANT FOODS SELL 1234.00 1228.00 1220.00 1210.00 1240.00 Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, togethe r with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoev er for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.

×